Long term survival and predictors of disease reclassification in patients on an active surveillance protocol for prostate cancer.


INTRODUCTION Up to 50% of patients will have disease reclassification while on active surveillance (AS) for their prostate cancer. Determining which patients will have reclassification that will impact their survival is difficult. We investigated clinicopathologic factors associated with disease reclassification and differences in both overall and… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.